http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107865983-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107865983-B
titleOfInvention Medicine stent and preparation method thereof
abstract The invention belongs to the field of medical appliances, and particularly relates to a drug stent and a preparation method thereof. The drug stent comprises a stent body and a drug composition distributed on the stent body, wherein the drug composition consists of amlexanox, paclitaxel, sirolimus and aspirin. The preparation method comprises the following steps: first, a mixed powder or solution of the pharmaceutical composition is prepared, and then the prepared mixed powder or solution is used to load the drug on the surface of the stent body through a dripping, burying or coating method. The invention discovers that the composition of amlexanox, paclitaxel, sirolimus and aspirin has high activity of inhibiting smooth muscle cell proliferation, and after the composition is applied to a drug stent, compared with the current commonly used drug eluting stent, the composition also has the characteristic of low endothelial cell growth inhibition, so that the composition can prevent the incidence rate of vascular restenosis in the PTCA postoperative treatment process, and can not delay endothelial repair.
priorityDate 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007673-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153274811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426352332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028

Total number of triples: 41.